Header Logo

Connection

Robert Zurier to Receptor, Cannabinoid, CB2

This is a "connection" page, showing publications Robert Zurier has written about Receptor, Cannabinoid, CB2.
Connection Strength

0.160
  1. Tepper MA, Zurier RB, Burstein SH. Ultrapure ajulemic acid has improved CB2 selectivity with reduced CB1 activity. Bioorg Med Chem. 2014 Jul 01; 22(13):3245-51.
    View in: PubMed
    Score: 0.113
  2. Recht LD, Salmonsen R, Rosetti R, Jang T, Pipia G, Kubiatowski T, Karim P, Ross AH, Zurier R, Litofsky NS, Burstein S. Antitumor effects of ajulemic acid (CT3), a synthetic non-psychoactive cannabinoid. Biochem Pharmacol. 2001 Sep 15; 62(6):755-63.
    View in: PubMed
    Score: 0.047
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.